Abbott Laboratories (NYSE:ABT) Shares Bought by Retirement Systems of Alabama

EGOV's SI was 7.60 million shares in October as released by FINRA. Cadence Capital Limited Liability Corp has 0.61% invested in Abbott Laboratories (NYSE:ABT) for 181,050 shares. The SI to Abbott Labs's float is 0.77%.

Many analysts are providing their Estimated Earnings analysis for Abbott Laboratories and for the current quarter 18 analysts have projected that the stock could give an Average Earnings estimate of $0.73/share.

Westwood Holdings Group Inc decreased Abbott Labs (ABT) stake by 2.28% reported in 2017Q2 SEC filing. It has underperformed by 0.80% the S&P500. Ww Asset Management Inc owns 0.27% invested in Abbott Laboratories (NYSE:ABT) for 163,865 shares. In the last ninety days, insiders have sold 410,313 shares of company stock worth $21,303,676. About shares traded. Invesco Ltd. (NYSE:IVZ) has risen 9.83% since October 27, 2016 and is uptrending.

Since June 15, 2017, it had 0 insider buys, and 1 insider sale for $26,482 activity. The shares were sold at an average price of $52.95, for a total value of $3,307,257.00.

Tenneco a producer of clean air and ride performance products and systems for light vehicle, commercial truck, off-highway and other vehicle applications. The Firm designs, makes and distributes highly engineered products for both original equipment vehicle manufacturers and the fix and replacement markets, or aftermarket, across the world. It has a 9.97 P/E ratio. Seven research analysts have rated the stock with a hold rating and ten have issued a buy rating to the company's stock. Teradyne had 32 analyst reports since August 25, 2015 according to SRatingsIntel. The rating was maintained by RBC Capital Markets with "Hold" on Monday, July 3. On Tuesday, September 22 the stock rating was initiated by UBS with "Neutral". On Wednesday, October 7 the stock rating was maintained by Jefferies with "Buy". The stock of Rolls-Royce Holding PLC (ADR) (OTCMKTS:RYCEY) has "Underperform" rating given on Tuesday, December 8 by Bernstein.

Investors of record on Friday, October 13th will be paid a $0.265 dividend. The difference between the expected and actual EPS was $0.01/share, which represents an Earnings surprise of 1.5%. It is negative, as 69 investors sold ABT shares while 545 reduced holdings. Dimensional Fund Advisors LP raised its holdings in Abbott Laboratories by 28.6% during the 2nd quarter. Jones Fin Lllp holds 155,788 shares or 0.02% of its portfolio. Gideon Cap has invested 0.87% in Teradyne, Inc. Metropolitan Life Insurance Co owns 840,284 shares for 0.28% of their portfolio. Johnson Investment Counsel Inc bought 19,801 shares as the company's stock declined 2.83% while stock markets rallied. Daniel Devine Company holds 5,335 shares or 0.21% of its portfolio. 390,396 are owned by Koch Indus Incorporated. Raymond James Fincl Advisors owns 0% invested in Invesco Ltd. (NYSE:IVZ) for 18,862 shares. It is positive, as 21 investors sold TER shares while 119 reduced holdings. Aviva Public Limited Com accumulated 1.07 million shares. About 5.16M shares traded or 128.32% up from the average. Zacks Investment Mgmt holds 0.03% or 37,215 shares. Jpmorgan Chase holds 0.2% or 17.96M shares in its portfolio. Rathbone Brothers Public Limited Com has invested 0.47% in Abbott Laboratories (NYSE:ABT). Therefore 71% are positive.

While looking at the Stock's Performance, Abbott Laboratories now shows a Weekly Performance of -0.93%, where Monthly Performance is 6.39%, Quarterly performance is 11.83%, 6 Months performance is 27.13% and yearly performance percentage is 38.84%. They now have $61.00 price target on the healthcare product maker's stock. Finally, Cowen and Company restated a buy rating on shares of Abbott Laboratories in a research report on Sunday, September 24th. Barclays Capital has "Overweight" rating and $36 target.

Abbott Laboratories (NYSE:ABT) issued an update on its fourth quarter earnings guidance on Wednesday morning. Deutsche Bank maintained the shares of IVZ in report on Thursday, June 16 with "Buy" rating. The firm has "Buy" rating given on Thursday, September 28 by Wells Fargo. Finally, Bank of America Corp. reissued a "buy" rating and issued a $50.00 target price on shares of Abbott Laboratories in a report on Friday, August 12th. Winfield Associates Inc. grew its holdings in shares of Abbott Laboratories by 3.9% in the 2nd quarter. The company was maintained on Thursday, April 20 by Barclays Capital. The stock has "Equal-Weight" rating by Morgan Stanley on Tuesday, July 11.

Abbott Laboratories (Abbott) is engaged in the discovery, development, manufacture and sale of a line of healthcare products. The company has market cap of $96.41 billion. The Company operates through four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products and Vascular Products. The company's P/E (price to earnings) ratio is 45.74 and Forward P/E ratio of 19.68. Its Established Pharmaceutical Products include a range of branded generic pharmaceuticals manufactured around the world and marketed and sold outside the United States.

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Like this



28 October 2017
Microsoft has officially killed off the Kinect
However, despite the decent sales record, Kinect couldn't quite achieve the kind of popularity that Microsoft may have hoped for. Fast forward seven years later, Microsoft has confirmed that it is halting production of the device.

28 October 2017
Burger King unveils new ad with McDonald's punchline
The new marketing campaign is not the first time Burger King has, as Business Insider said, "trolled" McDonald's. The burger chain is inviting clowns in select cities across the nation to "eat like a king" on Halloween.

28 October 2017
Eagles 'll be tough - Argentina coach
It was learnt that it was one major reason why Rohr made a decision to revive his pursuit of veteran France-based keeper Vincent Enyeama.

28 October 2017
MGM Resorts International (MGM), Franklin Resources, Inc. (BEN)
The company reported $0.31 earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of $0.28 by $0.03. They expect this year's earnings to fall -7.38% year-over-year to $1.13, followed by 24.78% growth in the next year to $1.41.

28 October 2017
Shiv Sena attacks BJP again; says Modi wave ended
Be it demonetisation, the launch of bullet train or the election campaign in Gujarat, the Shiv Sena has openly slammed the BJP. But it couldn't work out as NCP proposed that Shiv Sena and Congress would form government with its support from outside.

28 October 2017
The Bull Case for Union Pacific Corporation (UNP)
Current trade price levels places UNP's stock about -0.39% away from the 52-week high and closed 33.78% away from the 52-week low. The company has market cap of $17.91 million. 4 analysts say it's a Hold while 0 analysts provided their expert opinion as Sell.

28 October 2017
Your Next Southwest Flight Could Include a Live Concert (Surprise?)
After the concert, the singer strolled the aisles and gave out souvenir guitar picks as well as compact discs to his audience. Yesterday, Billboard broke the news that some Southwest Airlines flights will have "pop-up shows".

28 October 2017
Stocks Securing Modest Gains: Netflix, Inc. (NASDAQ:NFLX)
NFLX is now undervalued by -9% relative to the average 1-year price target of $214.51 taken from a group of Wall Street Analysts. The firm owned 53,740 shares of the Internet television network's stock after selling 630 shares during the period.

28 October 2017
Impeached VP of Clemson University's SGA says vote reflects racism
Student Senator Miller Hoffman , who is white, introduced the resolution to impeach Stewart, citing a leaked document describing alleged misconduct.

28 October 2017
Analyst Activity - Cowen and Company Reiterates Hold on Akamai Technologies (NASDAQ:AKAM)
The average investment rating for AKAM on a scale of 1 to 5 (1 being a strong sell and 5 being a strong buy) is a 3.68 or a Hold. In related news, CEO F Thomson Leighton acquired 21,554 shares of the company's stock in a transaction on Tuesday, August 15th.